These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23222849)

  • 1. Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.
    Gutmann DH; McLellan MD; Hussain I; Wallis JW; Fulton LL; Fulton RS; Magrini V; Demeter R; Wylie T; Kandoth C; Leonard JR; Guha A; Miller CA; Ding L; Mardis ER
    Genome Res; 2013 Mar; 23(3):431-9. PubMed ID: 23222849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.
    Wimmer K; Eckart M; Meyer-Puttlitz B; Fonatsch C; Pietsch T
    J Neuropathol Exp Neurol; 2002 Oct; 61(10):896-902. PubMed ID: 12387455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
    Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
    Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.
    Kluwe L; Hagel C; Tatagiba M; Thomas S; Stavrou D; Ostertag H; von Deimling A; Mautner VF
    J Neuropathol Exp Neurol; 2001 Sep; 60(9):917-20. PubMed ID: 11556548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.
    Gutmann DH; James CD; Poyhonen M; Louis DN; Ferner R; Guha A; Hariharan S; Viskochil D; Perry A
    Neurology; 2003 Nov; 61(10):1397-400. PubMed ID: 14638962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.
    Platten M; Giordano MJ; Dirven CM; Gutmann DH; Louis DN
    Am J Pathol; 1996 Aug; 149(2):621-7. PubMed ID: 8702000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.
    Ebinger M; Senf L; Wachowski O; Scheurlen W
    Pediatr Hematol Oncol; 2005; 22(1):83-7. PubMed ID: 15770836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
    Gutmann DH; Donahoe J; Brown T; James CD; Perry A
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):361-7. PubMed ID: 10931370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular and cell biology of pediatric low-grade gliomas.
    Chen YH; Gutmann DH
    Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.
    von Deimling A; Louis DN; Menon AG; von Ammon K; Petersen I; Ellison D; Wiestler OD; Seizinger BR
    Acta Neuropathol; 1993; 86(1):81-5. PubMed ID: 8103960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
    Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
    Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare NF1 Gene Mutation in Chinese Patient with Neurofibromatosis Type 1 and Anaplastic Astrocytoma.
    Zhou S; Zhu Y; Xu J; Tao R; Yuan S
    World Neurosurg; 2020 Feb; 134():434-437. PubMed ID: 31678437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1.
    Tada K; Kochi M; Saya H; Kuratsu J; Shiraishi S; Kamiryo T; Shinojima N; Ushio Y
    Neuro Oncol; 2003 Oct; 5(4):228-34. PubMed ID: 14565158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
    Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
    J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
    Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
    Upadhyaya M; Kluwe L; Spurlock G; Monem B; Majounie E; Mantripragada K; Ruggieri M; Chuzhanova N; Evans DG; Ferner R; Thomas N; Guha A; Mautner V
    Hum Mutat; 2008 Jan; 29(1):74-82. PubMed ID: 17960768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset.
    Jentoft M; Giannini C; Cen L; Scheithauer BW; Hoesley B; Sarkaria JN; Abell-Aleff PC; Rodriguez EF; Li Y; Rodriguez FJ
    Int J Clin Exp Pathol; 2010 Dec; 4(1):43-57. PubMed ID: 21228927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
    Perren A; Wiesli P; Schmid S; Montani M; Schmitt A; Schmid C; Moch H; Komminoth P
    Am J Surg Pathol; 2006 Aug; 30(8):1047-51. PubMed ID: 16861979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.